All In MedTech

Device Trial Radar · NCT01030341

Continuous Glucose Monitoring and Insulin Pump Therapy in Diabetic Gastroparesis

Pilot Study of the Safety, Feasibility, and Potential Efficacy of Continuous Glucose Monitoring and Insulin Pump Therapy in Diabetic Gastroparesis (GLUMIT-DG)

Last checked: Nov 20, 2026Latest source record: Feb 9, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

45

Actual

Start

May 2011

Primary completion

Nov 2014

Study completion Jan 2015

Sponsor

Lead sponsor
Johns Hopkins Bloomberg School of Public HealthAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
First posted
Dec 11, 2009

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A pilot study to assess the safety, feasibility, and potential (uncontrolled) efficacy of continuous glucose monitoring (CGMS) in conjunction with an insulin pump to improve glycemic control for treatment of type 1 and type 2 diabetic patients with gastroparesis

Conditions

  • Diabetic Gastroparesis

Interventions

  • CGMS and insulin pumpDevice

    Use of continuous glucose monitoring system and insulin pump

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Hypoglycemic EpisodesTime frame: 4 weeks screening vs 24 weeks follow-up

Locations

7 sites in 1 country. Site status is shown where the registry gives one.

  • California Pacific Medical Center

    San Francisco, California

  • Stanford University

    Stanford, California

  • University of Michigan Medical Center

    Ann Arbor, Michigan

4 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.